TCL Archive Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups September 30, 1988
TCL Archive FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union June 19, 1998
TCL Archive Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval January 27, 2006
TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma. December 1, 2000
